Christopher Verni
Algemeen Adviseur bij VIGIL NEUROSCIENCE, INC.
Vermogen: 12 720 $ op 31-05-2024
Actieve functies van Christopher Verni
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| VIGIL NEUROSCIENCE, INC. | Algemeen Adviseur | 20-04-2022 | - |
Loopbaan van Christopher Verni
Eerdere bekende functies van Christopher Verni
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| SAREPTA THERAPEUTICS, INC. | Corporate Officer/Principal | 01-12-2013 | 01-04-2022 |
| ARIAD PHARMACEUTICALS, INC. | Algemeen Adviseur | 01-10-2011 | 01-11-2013 |
| Sanofi SA | Algemeen Adviseur | 01-05-2007 | 01-10-2011 |
| PFIZER, INC. | Algemeen Adviseur | 01-05-2004 | 01-05-2007 |
Opleiding van Christopher Verni
| University of New Hampshire School of Law | Graduate Degree |
| Rochester Christian University | Undergraduate Degree |
Statistieken
Internationaal
| Verenigde Staten | 7 |
| Frankrijk | 2 |
Operationeel
| General Counsel | 4 |
| Graduate Degree | 1 |
| Undergraduate Degree | 1 |
Sectoraal
| Health Technology | 6 |
| Consumer Services | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 3 |
|---|---|
| VIGIL NEUROSCIENCE, INC. | Health Technology |
| SAREPTA THERAPEUTICS, INC. | Health Technology |
| PFIZER, INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
ARIAD Pharmaceuticals, Inc.
 ARIAD Pharmaceuticals, Inc. BiotechnologyHealth Technology ARIAD Pharmaceuticals, Inc. operates as an oncology company, which engages in the discovery, development, and commercialization of small-molecule drugs for the treatment of cancer. The company was founded by Harvey J. Berger and James E. Rothman on January 8, 1992 and is headquartered in Cambridge, MA. | Health Technology |
| Sanofi SA | Health Technology |
- Beurs
- Insiders
- Christopher Verni
- Ervaring
